150 related articles for article (PubMed ID: 95308)
1. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
Camm J; Ward D; Washington HG; Spurrell RA
Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
[TBL] [Abstract][Full Text] [Related]
2. Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.
Camm J; Ward D; Spurrell R
Br Heart J; 1980 Sep; 44(3):240-7. PubMed ID: 7426181
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.
Sethi KK; Jaishankar S; Khalilullah M; Gupta MP
Br Heart J; 1983 Jun; 49(6):532-43. PubMed ID: 6849716
[TBL] [Abstract][Full Text] [Related]
4. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
Lerman BB; Waxman HL; Buxton AE; Josephson ME
Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
Camm J; Ward D; Spurrell RA
Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
[TBL] [Abstract][Full Text] [Related]
6. Autodecremental pacing--a microprocessor based modality for the termination of paroxysmal tachycardias.
Ward DE; Camm AJ; Gainsborough J; Spurrell RA
Pacing Clin Electrophysiol; 1980 Mar; 3(2):178-91. PubMed ID: 6160507
[TBL] [Abstract][Full Text] [Related]
7. Rate-related accelerating (autodecremental) atrial pacing for reversion of paroxysmal supraventricular tachycardia.
Nathan A; Hellestrand K; Ward D; Spurrell R; Camm J
J Electrocardiol; 1982 Jan; 15(1):77-84. PubMed ID: 7069321
[TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
Manz M; Steinbeck G; Nitsch J; Lüderitz B
Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
[TBL] [Abstract][Full Text] [Related]
9. Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing.
Della Bella P; Tondo C; Marenzi G; Cipolla CM; Doni F; Grazi S; Rimondini A; Salvioni A; Guazzi MD
Am J Cardiol; 1988 May; 61(13):1046-9. PubMed ID: 3284318
[TBL] [Abstract][Full Text] [Related]
10. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
[TBL] [Abstract][Full Text] [Related]
11. Termination of ventricular tachycardia with bursts of rapid ventricular pacing.
Fisher JD; Mehra R; Furman S
Am J Cardiol; 1978 Jan; 41(1):94-102. PubMed ID: 623012
[TBL] [Abstract][Full Text] [Related]
12. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
[No Abstract] [Full Text] [Related]
13. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous and oral disopyramide on paroxysmal atrioventricular nodal tachycardia.
Brugada P; Wellens HJ
Am J Cardiol; 1984 Jan; 53(1):88-92. PubMed ID: 6362389
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of pacing techniques for termination of well-tolerated sustained ventricular tachycardia.
Fisher JD; Kim SG; Matos JA; Ostrow E
Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):915-22. PubMed ID: 6195611
[TBL] [Abstract][Full Text] [Related]
17. Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia.
Naccarelli GV; Zipes DP; Rahilly GT; Heger JJ; Prystowsky EN
Am Heart J; 1983 Jan; 105(1):1-5. PubMed ID: 6849222
[TBL] [Abstract][Full Text] [Related]
18. Pacing hazards in helicopter aeromedical transport.
Sumchai A; Sternbach G; Eliastam M; Liem LB
Am J Emerg Med; 1988 May; 6(3):236-40. PubMed ID: 3370099
[TBL] [Abstract][Full Text] [Related]
19. Observations on induction and termination of paroxysmal supraventricular tachycardia by external pacing.
Grubb BP; Markel ML; Artman SE; Post WR; Luck JC
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):1944-52. PubMed ID: 1279577
[TBL] [Abstract][Full Text] [Related]
20. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Griffith MJ; Linker NJ; Garratt CJ; Ward DE; Camm AJ
Lancet; 1990 Sep; 336(8716):670-3. PubMed ID: 1975861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
